Publications by authors named "Redouane Tabti"

Claim this Profile
T
The prohibitin ligand IN44 decreases Porphyromonas gingivalis mediated inflammation.
Céline Stutz, Pierre-Yves Gegout, Chloé Bloch, Hayriye Özçelik, Nicolas Anton, Redouane Tabti

BMC Oral Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of prohibitin ligands against osteoporosis.
Redouane Tabti, François Lamoureux, Céline Charrier, Benjamin Ory, Dominique Heymann

Eur J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SFPH proteins as therapeutic targets for a myriad of diseases.
Dong Wang, Redouane Tabti, Sabria Elderwish, Amel Djehal, Nora Chouha

Bioorg Med Chem Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria.
Carolin Ploeger, Thorben Huth, Raisatun Nisa Sugiyanto, Stefan Pusch, Benjamin Goeppert, Redouane Tabti

Cell Death Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.
Dong Wang, Redouane Tabti, Sabria Elderwish, Hussein Abou-Hamdan, Amel Djehal

Cell Mol Life Sci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Synthetic Small Molecule FL3 Combats Intestinal Tumorigenesis via Axin1-Mediated Inhibition of Wnt/β-Catenin Signaling.
Dakota N Jackson, Kibrom M Alula, Yaritza Delgado-Deida, Redouane Tabti, Kevin Turner

Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis